US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Propanc Biopharma, Inc.

5.75

0.0000

Volume:- -

Turnover:- -

Market Cap:88.55K

PE:- -

High:5.75

Open:5.75

Low:5.75

Close:5.75

52wk High:145.46

52wk Low:2.76

Shares:15.40K

Float Shares:15.40K

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(LYR):-192.4463

ROE:--

ROA:-462.23%

PB:-0.02

PE(LYR):-0.03

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Propanc Biopharma, Inc.

Exchange:

PINK

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.propanc.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Propanc Biopharma, Inc., a development-stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of JaÃ©n to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was founded in 2007 and is based in Camberwell, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PPCBD/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PPCBD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCBD\",,,,,undefined,":{"symbol":"PPCBD","market":"US","secType":"STK","nameCN":"Propanc Biopharma, Inc.","latestPrice":5.75,"timestamp":1757016000000,"preClose":5.75,"halted":0,"volume":0,"delay":15,"floatShares":15400,"shares":15400,"eps":0,"marketStatus":"Post-Mkt","change":0,"latestTime":"09-04 16:00:00 EDT Delay","open":5.75,"high":5.75,"low":5.75,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1757030400000},"marketStatusCode":4,"adr":0,"exchange":"PINK","adjPreClose":5.75,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCBD\",,,,,undefined,":{"symbol":"PPCBD","floatShares":15400,"roa":"-462.23%","roe":"--","lyrEps":-192.446334,"shares":15400,"dividePrice":0,"high":5.75,"amplitude":0,"preClose":5.75,"low":5.75,"week52Low":2.76,"pbRate":"-0.02","week52High":145.46,"institutionHeld":0,"latestPrice":5.75,"eps":0,"divideRate":0,"volume":0,"delay":15,"open":5.75,"prevYearClose":0.055,"prevWeekClose":5.75,"prevMonthClose":5.75,"prevQuarterClose":5.75,"fiveDayClose":5.75,"twentyDayClose":5.75,"sixtyDayClose":5.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPCBD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2023-06-22","symbol":"PPCBD","oldSymbol":"PPCBD","defaultRemindTime":1687440600000,"newSymbol":"PPCB","exchange":"PINK","type":"symbolChange","dateTimestamp":1687406400000},{"market":"US","date":"2020-11-19","symbol":"PPCBD","type":"split","dateTimestamp":1605762000000,"forFactor":1000,"toFactor":1,"ratio":1000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPCBD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPCBD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.propanc.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.3254},{"period":"6month","weight":0.7768},{"period":"ytd","weight":0.7768}],"description":"Propanc Biopharma, Inc., a development-stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of JaÃ©n to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was founded in 2007 and is based in Camberwell, Australia.","exchange":"PINK","name":"Propanc Biopharma, Inc.","nameEN":"Propanc Biopharma, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PPCBD\",market:\"US\",,,undefined,":null}}